Prot #1620303: An Open Label, Multi-Center Trial to Assess the Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines (SAKURA OPEN LABEL SAFETY)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/11/17 → 4/11/20

Funding

  • Novella Clinical, LLC (Prot #1620303)
  • Revance Therapeutics, Inc. (Prot #1620303)